238 related articles for article (PubMed ID: 2825911)
1. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats.
Nikolarakis K; Pfeiffer A; Stalla GK; Herz A
Brain Res; 1987 Sep; 421(1-2):373-6. PubMed ID: 2825911
[TBL] [Abstract][Full Text] [Related]
2. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
[TBL] [Abstract][Full Text] [Related]
3. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways.
Nikolarakis KE; Pfeiffer A; Stalla GK; Herz A
Brain Res; 1989 Oct; 498(2):385-8. PubMed ID: 2551464
[TBL] [Abstract][Full Text] [Related]
5. [Effects of kappa-opiate receptor antagonist MR-2266-BS on ACTH and prolactin release].
Xu RK; Chen L; Li H; Yang SJ; Huang XY
Sheng Li Xue Bao; 1989 Aug; 41(4):395-401. PubMed ID: 2557673
[TBL] [Abstract][Full Text] [Related]
6. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
[TBL] [Abstract][Full Text] [Related]
7. Effects of corticotropin-releasing factor (CRF) and opiates on amphibian locomotion.
Lowry CA; Deviche P; Moore FL
Brain Res; 1990 Apr; 513(1):94-100. PubMed ID: 2161698
[TBL] [Abstract][Full Text] [Related]
8. Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro.
Tsagarakis S; Rees LH; Besser M; Grossman A
Neuroendocrinology; 1990 May; 51(5):599-605. PubMed ID: 2162017
[TBL] [Abstract][Full Text] [Related]
9. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
Tsagarakis S; Navarra P; Rees LH; Besser M; Grossman A; Navara P
Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975
[TBL] [Abstract][Full Text] [Related]
10. Mu opiate isoreceptors: differentiation with kappa agonists.
Wood PL; Richard JW; Thakur M
Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
[TBL] [Abstract][Full Text] [Related]
11. Psychotomimesis mediated by kappa opiate receptors.
Pfeiffer A; Brantl V; Herz A; Emrich HM
Science; 1986 Aug; 233(4765):774-6. PubMed ID: 3016896
[TBL] [Abstract][Full Text] [Related]
12. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
[TBL] [Abstract][Full Text] [Related]
13. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism.
Rivier C; Vale W
Brain Res; 1987 Oct; 422(2):403-6. PubMed ID: 2823980
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area.
Sirinathsinghji DJ
Brain Res; 1986 Jun; 375(1):49-56. PubMed ID: 3013371
[TBL] [Abstract][Full Text] [Related]
15. Relative effectiveness of naloxone and MR2266 in potentiating oestrogen-stimulated luteinizing hormone surges in ovariectomized female rats.
Dyer RG; Mansfield S; Dean AD
Neurosci Lett; 1984 Aug; 49(1-2):111-5. PubMed ID: 6093001
[TBL] [Abstract][Full Text] [Related]
16. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
Huidobro-Toro JP; Parada S
Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
[TBL] [Abstract][Full Text] [Related]
17. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
Buckingham JC; Cooper TA
Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
[TBL] [Abstract][Full Text] [Related]
18. Further study of kappa opioids on increased urination.
Leander JD
J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
[TBL] [Abstract][Full Text] [Related]
19. Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections.
Kim HS; Iyengar S; Wood PL
Life Sci; 1987 Oct; 41(14):1711-5. PubMed ID: 2821337
[TBL] [Abstract][Full Text] [Related]
20. Opioid kappa-receptor agonists suppress sexual behaviors in male rough-skinned newts (Taricha granulosa).
Deviche P; Moore FL
Horm Behav; 1987 Sep; 21(3):371-83. PubMed ID: 2822565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
